21 May 2009
Vitreous amyloidosis in two sisters as the indication of transthyretin-related familial form of systemic amyloidosis
R Niemczyk, J Brydak-Godowska, D Kęcik, T Wagner, P Lewandowski, M Kęcik, D Zygier, U Ołdakowska-JedynakAnn Transplant 2009; 14(1): 43-43 :: ID: 880355
Abstract
Background: Vitreous amyloidosis is a very rare condition characteristic of
hereditary systemic amyloidosis associated with polyneuropathy, which is
caused by transthyretin (TTR) gene mutation. The aim of this paper is to
present two sisters in whm vitreous involvement was the indication of TTR-
related familial form of systemic amyloidosis.
Material/Methods: Report of two cases.
Results: Two sisters (36- and 40-year-old) presented with gradual bilateral deterioration of vision for a few months. The younger one has had sensory disorders and increasing weakness of lower extremities for few years. Their father died in the age of 44 with symptoms of advanced polyneuropathy and blindness of unknown aetiology. Based on ophthalmologic examination vitreous amyloidosis was suspected in both sisters. In the older patient successful pars plana vitrectomy of the right eye was performed because of significant vision loss. The histopathological examination of subcutaneous fat in both patients and additionally of vitreous specimens in older sister confirmed the diagnosis of TTR- related familial form of systemic amyloidosis. During follow-up significant deterioration of clinical condition with progressive motor disability and autonomic disorders was observed in the younger patient. Due to progressive nature of the disease and poor prognosis, the patients were qualified to the liver transplantation, which is now the only effective treatment of the disease.
Conclusions: Vitreous amyloidosis should be included into differential diagnosis of changes in the vitreous, especially when neurologic manifestation and positive family history co-exist. The ophthalmoscopic characteristics of this very rare disease may lead to the diagnosis of TTR-related familial form of systemic amyloidosis associated with polyneuropathy and allow to implement the proper therapy.
Keywords: Liver Transplantation, case report
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






